Purpose Acute ischemic injury is a strong inductor of cardiac remodelling, resulting in structural changes of the extracellular matrix (ECM) and basement membrane (BM). In a large animal model of ischemia-reperfusion (I/R) we investigated the post-ischemic liberation of the collagen-IV-fragments Tumstatin (TUM; 28 kDa-fragment of collagen-IV-alpha-3), Arresten (ARR; 26 kDa-fragment of collagen-IV-alpha-1) and Endorepellin (LG3, 85 kDa-fragment of perlecan) which are biologically active in angiogenesis and vascularization in the post-ischemic myocardium. Methods and Results In this blinded study, 30 pigs were randomized to 60 min of global I/R at either 4°C or 32°C or served as control. Three transmyocardial tissue samples were collected prior to ischemia and within 30 min and 150 min of reperfusion. Tissue content of TUM, ARR and LG3 was analyzed by western blotting and immunostaining. Within 150 min of mild hypothermic I/R a significantly increased tissue content of ARR (0.17±0.14 vs. 0.56±0.56; p = 0.001) and LG3 (1.13±0.34 vs. 2.51±1.71, p<0.001) was observed. In contrast, deep hypothermic I/R was not associated with a significant release of cleavage products. Cleavage of TUM remained unchanged irrespective of temperature. Increased matrix processing following mild hypothermia I/R is further supported by a >11fold elevation of creatine kinase (2075±2595 U/l vs. 23248±6551 U/l; p<0.001) in the coronary sinus plasma samples. Immunostaining demonstrated no changes for ARR and LG3 presentation irrespective of temperature. In contrast, TUM significantly decreased in the BM surrounding cardiomyocytes and capillaries after mild and deep hypothermic I/R, thus representing structural alterations of the BM in these groups. Conclusion The study demonstrates an early temperature-dependent processing of Col-IV as major component of the BM of cardiomyocytes and vascular endothelium. These observations support the protective effects of deep hypothermia during I/R. Furthermore, the results suggest an increased structural remodelling of the myocardial basement membrane with potential functional impairment during mild hypothermic I/R which may contribute to the progression to post-ischemic heart failure.
References
[1]
Bendrik C, Karlsson L, Dabrosin C (2010) Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer. Cancer Lett 292: 32–40. doi: 10.1016/j.canlet.2009.11.002
[2]
Cailhier JF, Sirois I, Laplante P, Lepage S, Raymond MA, et al. (2008) Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem 283: 27220–27229. doi: 10.1074/jbc.m801164200
[3]
Cleutjens JP (1996) The role of matrix metalloproteinases in heart disease. Cardiovasc Res 32: 816–821. doi: 10.1016/s0008-6363(96)00104-6
[4]
Creemers EE, Cleutjens JP, Smits JF, Daemen MJ (2001) Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89: 201–210. doi: 10.1161/hh1501.094396
[5]
Falk V, Soccal PM, Grunenfelder J, Hoyt G, Walther T, et al. (2002) Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury. Eur J Cardiothorac Surg 22: 53–58. doi: 10.1016/s1010-7940(02)00207-5
[6]
Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, et al. (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3: 589–601. doi: 10.1016/s1535-6108(03)00133-8
[7]
He KL, Dickstein M, Sabbah HN, Yi GH, Gu A, et al. (2004) Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res 64: 72–83. doi: 10.1016/j.cardiores.2004.06.007
[8]
Jugdutt BI (2003) Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108: 1395–1403. doi: 10.1161/01.cir.0000085658.98621.49
[9]
Kruegel J, Miosge N (2010) Basement membrane components are key players in specialized extracellular matrices. Cell Mol Life Sci 67: 2879–2895. doi: 10.1007/s00018-010-0367-x
[10]
Laplante P, Raymond MA, Labelle A, Abe J, Iozzo RV, et al. (2006) Perlecan proteolysis induces an alpha2beta1 integrin- and Src family kinase-dependent anti-apoptotic pathway in fibroblasts in the absence of focal adhesion kinase activation. J Biol Chem 281: 30383–30392. doi: 10.1074/jbc.m606412200
[11]
Lauten A, Ferrari M, Petri A, Ensminger SM, Gummert JF, et al. (2009) Experimental evaluation of the JenaClip transcatheter aortic valve. Catheter Cardiovasc Interv 74: 514–519. doi: 10.1002/ccd.22093
[12]
Lauten A, Majos E, Muhlich A, Wahlers T, Weider S, et al. (2009) Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol 104: 559–569. doi: 10.1007/s00395-009-0013-7
[13]
Lerman RH, Apstein CS, Kagan HM, Osmers EL, Chichester CO, et al. (1983) Myocardial healing and repair after experimental infarction in the rabbit. Circ Res 53: 378–388. doi: 10.1161/01.res.53.3.378
[14]
Maeshima Y, Colorado PC, Kalluri R (2000) Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 275: 23745–23750. doi: 10.1074/jbc.c000186200
[15]
Malan D, Reppel M, Dobrowolski R, Roell W, Smyth N, et al. (2009) Lack of laminin gamma1 in embryonic stem cell-derived cardiomyocytes causes inhomogeneous electrical spreading despite intact differentiation and function. Stem Cells 27: 88–99. doi: 10.1634/stemcells.2008-0335
[16]
Maragoudakis ME, Haralabopoulos GC, Tsopanoglou NE, Pipili-Synetos E (1995) Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods. Microvasc Res 50: 215–222. doi: 10.1006/mvre.1995.1054
[17]
Maragoudakis ME, Missirlis E, Karakiulakis GD, Sarmonica M, Bastakis M, et al. (1993) Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. Kidney Int 43: 147–150. doi: 10.1038/ki.1993.24
[18]
Mellon MJ, Bae KH, Steding CE, Jimenez JA, Kao C, et al. (2008) Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapy. Hum Gene Ther 19: 487–495. doi: 10.1089/hum.2007.135
[19]
Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 278: 4238–4249. doi: 10.1074/jbc.m210445200
[20]
Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, et al. (1999) Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10: 1361–1375. doi: 10.1111/j.1540-8167.1999.tb00192.x
[21]
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277–285. doi: 10.1016/s0092-8674(00)81848-6
[22]
Raymond MA, Desormeaux A, Laplante P, Vigneault N, Filep JG, et al. (2004) Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. Faseb J 18: 705–707. doi: 10.1096/fj.03-0573fje
[23]
Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, et al. (2002) Cellular cardiomyoplasty improves survival after myocardial injury. Circulation 105: 2435–2441. doi: 10.1161/01.cir.0000016063.66513.bb
[24]
Sabbah HN, Sharov VG, Gupta RC, Mishra S, Rastogi S, et al. (2003) Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res 93: 1095–1101. doi: 10.1161/01.res.0000101932.70443.fe
[25]
Sasse P, Malan D, Fleischmann M, Roell W, Gustafsson E, et al. (2008) Perlecan is critical for heart stability. Cardiovasc Res 80: 435–444. doi: 10.1093/cvr/cvn225
[26]
Schmidt A, Wenzel D, Ferring I, Kazemi S, Sasaki T, et al. (2004) Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn 230: 468–480. doi: 10.1002/dvdy.20072
[27]
Schrickel JW, Brixius K, Herr C, Clemen CS, Sasse P, et al. (2007) Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res 76: 257–268. doi: 10.1016/j.cardiores.2007.07.001
Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87: 1285–1342. doi: 10.1152/physrev.00012.2007
[30]
Spinale FG, Koval CN, Deschamps AM, Stroud RE, Ikonomidis JS (2008) Dynamic changes in matrix metalloprotienase activity within the human myocardial interstitium during myocardial arrest and reperfusion. Circulation 118: S16–23. doi: 10.1161/circulationaha.108.786640
[31]
Suhr F, Rosenwick C, Vassiliadis A, Bloch W, Brixius K (2009) Regulation of extracellular matrix compounds involved in angiogenic processes in short- and long-track elite runners. Scand J Med Sci Sports doi: 10.1111/j.1600-0838.2009.00960.x
[32]
Takahashi S, Barry AC, Factor SM (1990) Collagen degradation in ischaemic rat hearts. Biochem J 265: 233–241.
[33]
van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, et al. (2004) Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 109: 1048–1055. doi: 10.1161/01.cir.0000117402.70689.75
[34]
Wenzel D, Schmidt A, Reimann K, Hescheler J, Pfitzer G, et al. (2006) Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ Res 98: 1203–1211. doi: 10.1161/01.res.0000219899.93384.ed
